Patents by Inventor Ferenc Misák

Ferenc Misák has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Veterinary vaccine
    Patent number: 9687544
    Abstract: The present invention relates to novel compositions for inducing an immune response in mammals. The composition preferably comprises an antigen and a lipopolysaccharide in an oil-in-water formulation. The invention is particularly suited to vaccinate swine against mycoplasma infections.
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: June 27, 2017
    Assignee: CEVA SANTE ANIMALE
    Inventors: Jerome Thevenon, Ferenc Misak, Miklos Tenk
  • NOVEL VETERINARY VACCINE
    Publication number: 20150174240
    Abstract: The present invention relates to novel compositions for inducing an immune response in mammals. The composition preferably comprises an antigen and a lipopolysaccharide in an oil-in-water formulation. The invention is particularly suited to vaccinate swine against mycoplasma infections.
    Type: Application
    Filed: March 7, 2012
    Publication date: June 25, 2015
    Inventors: Jerome Thevenon, Ferenc Misak, Miklos Tenk
  • Porcine circovirus type 2B isolate and uses thereof
    Patent number: 8703468
    Abstract: The present invention relates to the novel Porcine Circovirus type 2 subtype B (PCV2B-Rm) isolate which comprises a short duplication of sequence and is adapted to grow in cell culture and may be propagated at high titres constantly up to 106 TCID50 viral particles per mL. This novel isolate is particularly useful for the production of porcine circovirus type 2 (PCV2) vaccines, for treating and/or preventing and/or diagnosing porcine circovirus associated diseases, as well as for diagnosing the presence of porcine circovirus in pigs. The present invention also relates to novel cell clones derived from Swine Testicles (ST) useful for propagating PCV2 and to a method for production of PCV2 virus with particularly high titers.
    Type: Grant
    Filed: November 27, 2009
    Date of Patent: April 22, 2014
    Assignee: Ceva Sante Animale
    Inventors: Zoltan Penzes, Ferenc Misák, Tamás Tuboly, Attila Csagola
  • Novel Porcine Circovirus Type 2B Isolate and Uses Thereof
    Publication number: 20120040438
    Abstract: The present invention relates to the novel Porcine Circovirus type 2 subtype B (PCV2B-Rm) isolate which comprises a short duplication of sequence and is adapted to grow in cell culture and may be propagated at high titres constantly up to 106 TCID50 viral particles per mL. This novel isolate is particularly useful for the production of porcine circovirus type 2 (PCV2) vaccines, for treating and/or preventing and/or diagnosing porcine circovirus associated diseases, as well as for diagnosing the presence of porcine circovirus in pigs. The present invention also relates to novel cell clones derived from Swine Testicles (ST) useful for propagating PCV2 and to a method for production of PCV2 virus with particularly high titers.
    Type: Application
    Filed: November 27, 2009
    Publication date: February 16, 2012
    Applicant: CEVA SANTE ANIMALE
    Inventors: Zoltan Penzes, Ferenc Misák, Tamás Tuboly, Attila Csagola